Literature DB >> 32451799

Recent advances in three-dimensional electroanatomical mapping guidance for the ablation of complex atrial and ventricular arrhythmias.

Paolo Compagnucci1, Giovanni Volpato2, Umberto Falanga2, Laura Cipolletta2, Manuel Conti2, Gino Grifoni2, Letizia Verticelli2, Nicolò Schicchi3, Andrea Giovagnoni3,4, Michela Casella2,4, Federico Guerra2,5, Antonio Dello Russo2,5.   

Abstract

PURPOSE: To provide a brief overview of some relevant technological advances in the field of three-dimensional electroanatomical mapping (3D-EAM) that have recently entered the clinical arena and their role in guiding catheter ablation (CA) of complex atrial and ventricular arrhythmias.
METHODS: In this technical report, we describe the general features of three novel algorithms featured in the updated CARTO PRIME™ mapping module for CARTO®3 version 7 3D-EAM system (Biosense Webster Inc., Diamond Bar, CA, USA): local activation time (LAT) hybrid, coherent mapping and map replay modules. We also report three challenging arrhythmia cases in which CA was successfully guided by these softwares.
RESULTS: The LAT hybrid module was used in a case of premature ventricular complex originating from the right coronary cusp. This algorithm facilitated safe positioning of the ablation catheter away from the right coronary ostium, avoiding potential harm to this vital structure. The coherent mapping module helped to identify the critical as well as a bystander isthmus of an atrial macro-re-entrant tachycardia in a grown-up patient with congenital heart disease. The map replay module allowed rapid retrospective activation mapping of two unstable ventricular tachycardias in a case of nonischemic cocaine-associated cardiomyopathy.
CONCLUSION: 3D-EAM systems offer significant advantages in the management of challenging arrhythmias, and the introduction of novel algorithms underpins improvements in patients' outcomes. Given the increasing sophistication of these systems, however, a close collaboration among cardiac electrophysiologists, engineers and technicians is highly needed in order to get the best from the available technology.

Entities:  

Keywords:  Arrhythmias; Atrial arrhythmias in congenital heart disease; Cardiac; Macro-re-entrant atrial tachycardia ablation; Premature ventricular complex ablation; Three-dimensional electroanatomical mapping; Unstable ventricular tachycardia ablation

Year:  2020        PMID: 32451799     DOI: 10.1007/s10840-020-00781-3

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  1 in total

1.  Premature ventricular contractions cause a position shift in 3D mapping systems: analysis, quantification, and correction by hybrid activation mapping.

Authors:  Tom De Potter; Konstantinos Iliodromitis; Tal Bar-On; Etel Silva Garcia; Joris Ector
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

  1 in total
  8 in total

Review 1.  [New mapping tools for catheter ablation of atrial fibrillation].

Authors:  Maryuri Delgado-López; Christian-Hendrik Heeger; Roland Richard Tilz
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2022-10-14

2.  Safety and Efficacy of Stereotactic Arrhythmia Radioablation for the Treatment of Ventricular Tachycardia: A Systematic Review.

Authors:  Giovanni Volpato; Paolo Compagnucci; Laura Cipolletta; Quintino Parisi; Yari Valeri; Laura Carboni; Andrea Giovagnoni; Antonio Dello Russo; Michela Casella
Journal:  Front Cardiovasc Med       Date:  2022-08-22

3.  Spatial correction improves accuracy of catheter positioning during ablation of premature ventricular contractions: differences between ventricular outflow tracts and other localizations.

Authors:  M Nies; R Schleberger; L Dinshaw; N Klatt; P Muenkler; C Jungen; L Rottner; M D Lemoine; B Reißmann; A Rillig; A Metzner; P Kirchhof; C Meyer
Journal:  BMC Cardiovasc Disord       Date:  2022-07-13       Impact factor: 2.174

4.  Zero Fluoroscopy Arrhythmias Catheter Ablation: A Trend Toward More Frequent Practice in a High-Volume Center.

Authors:  Federica Troisi; Pietro Guida; Federico Quadrini; Antonio Di Monaco; Nicola Vitulano; Rosa Caruso; Rocco Orfino; Giacomo Cecere; Matteo Anselmino; Massimo Grimaldi
Journal:  Front Cardiovasc Med       Date:  2022-04-28

5.  Ablation Index Predicts Successful Ablation of Focal Atrial Tachycardia: Results of a Multicenter Study.

Authors:  Paolo Compagnucci; Antonio Dello Russo; Marco Bergonti; Matteo Anselmino; Giulio Zucchelli; Alessio Gasperetti; Laura Cipolletta; Giovanni Volpato; Ciro Ascione; Federico Ferraris; Yari Valeri; Maria Grazia Bongiorni; Andrea Natale; Claudio Tondo; Gaetano Maria De Ferrari; Michela Casella
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

Review 6.  Atrial conduction velocity mapping: clinical tools, algorithms and approaches for understanding the arrhythmogenic substrate.

Authors:  Sam Coveney; Chris Cantwell; Caroline Roney
Journal:  Med Biol Eng Comput       Date:  2022-07-22       Impact factor: 3.079

Review 7.  Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases.

Authors:  Giovanni Volpato; Umberto Falanga; Laura Cipolletta; Manuel Antonio Conti; Gino Grifoni; Giuseppe Ciliberti; Alessia Urbinati; Alessandro Barbarossa; Giulia Stronati; Marco Fogante; Marco Bergonti; Valentina Catto; Federico Guerra; Andrea Giovagnoni; Antonio Dello Russo; Michela Casella; Paolo Compagnucci
Journal:  Medicina (Kaunas)       Date:  2021-03-25       Impact factor: 2.430

Review 8.  Myocardial Inflammation, Sports Practice, and Sudden Cardiac Death: 2021 Update.

Authors:  Paolo Compagnucci; Giovanni Volpato; Umberto Falanga; Laura Cipolletta; Manuel Antonio Conti; Gino Grifoni; Giuseppe Ciliberti; Giulia Stronati; Marco Fogante; Marco Bergonti; Elena Sommariva; Federico Guerra; Andrea Giovagnoni; Antonio Dello Russo; Michela Casella
Journal:  Medicina (Kaunas)       Date:  2021-03-17       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.